HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fumio Matsumura Selected Research

Dioxins

10/2016Polyuria-associated hydronephrosis induced by xenobiotic chemical exposure in mice.
2/2014Predominant role of cytosolic phospholipase A2α in dioxin-induced neonatal hydronephrosis in mice.
6/2011Activation of aryl hydrocarbon receptor induces vascular inflammation and promotes atherosclerosis in apolipoprotein E-/- mice.
11/2010TCDD induced pericardial edema and relative COX-2 expression in medaka (Oryzias Latipes) embryos.
10/2010Non-genomic action of TCDD to induce inflammatory responses in HepG2 human hepatoma cells and in liver of C57BL/6J mice.
7/2009Characterization of MCF mammary epithelial cells overexpressing the Arylhydrocarbon receptor (AhR).
2/2009The significance of the nongenomic pathway in mediating inflammatory signaling of the dioxin-activated Ah receptor to cause toxic effects.
12/2008Significance of the nongenomic, inflammatory pathway in mediating the toxic action of TCDD to induce rapid and long-term cellular responses in 3T3-L1 adipocytes.
9/2008Critical role of cyclooxygenase-2 activation in pathogenesis of hydronephrosis caused by lactational exposure of mice to dioxin.
11/2007Pathogenesis of aryl hydrocarbon receptor-mediated development of lymphoma is associated with increased cyclooxygenase-2 expression.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fumio Matsumura Research Topics

Disease

15Inflammation (Inflammations)
01/2021 - 11/2006
9Neoplasms (Cancer)
05/2015 - 09/2003
8Breast Neoplasms (Breast Cancer)
05/2015 - 01/2002
7Wasting Syndrome (Wasting Disease)
05/2015 - 03/2002
5Hydronephrosis
10/2016 - 09/2008
3Atherosclerosis
06/2011 - 01/2004
3Hepatocellular Carcinoma (Hepatoma)
10/2010 - 03/2004
2Hypersensitivity (Allergy)
05/2015 - 12/2012
2Asthma (Bronchial Asthma)
12/2012 - 06/2012
2Starvation
10/2011 - 01/2006
2Leukemia
03/2008 - 11/2007
2Poisoning
10/2007 - 08/2003
2Carcinogenesis
01/2004 - 01/2004
1Polyuria
10/2016
1Listeriosis (Listeria Infection)
12/2013
1Atherosclerotic Plaque (Atheroma)
06/2011
1Shock
11/2010
1Edema (Dropsy)
11/2010
1Bone Resorption
05/2009
1Lymphoma (Lymphomas)
11/2007
1Hyperlipidemias (Hyperlipidemia)
10/2007
1Type 2 Diabetes Mellitus (MODY)
11/2006

Drug/Important Bio-Agent (IBA)

24Polychlorinated Dibenzodioxins (TCDD)IBA
05/2015 - 03/2002
15DioxinsIBA
10/2016 - 08/2003
9Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
05/2015 - 01/2004
8Messenger RNA (mRNA)IBA
12/2012 - 01/2004
6Cyclooxygenase 2 (Cyclooxygenase-2)IBA
02/2014 - 01/2004
5CytokinesIBA
05/2015 - 11/2005
5LigandsIBA
05/2015 - 01/2004
4Environmental Pollutants (Pollutants, Environmental)IBA
05/2015 - 11/2007
3Estrogen ReceptorsIBA
05/2015 - 08/2011
3beta-hexachlorocyclohexaneIBA
07/2007 - 01/2002
2ChemokinesIBA
01/2021 - 06/2011
2Dinoprostone (PGE2)FDA Link
10/2016 - 02/2014
2Proteins (Proteins, Gene)FDA Link
10/2016 - 03/2004
2XenobioticsIBA
10/2016 - 09/2008
2Polychlorinated Biphenyls (PCBs)IBA
05/2015 - 06/2012
2Tyrosine (L-Tyrosine)FDA Link
05/2015 - 01/2004
2LipidsIBA
05/2015 - 01/2004
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2015 - 01/2006
2fascinIBA
12/2013 - 09/2002
2Interleukin-8 (Interleukin 8)IBA
08/2011 - 06/2011
2Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
11/2010 - 08/2003
2Arachidonic Acid (Vitamin F)IBA
11/2010 - 07/2008
2Toxic ActionsIBA
07/2009 - 09/2006
2src-Family KinasesIBA
02/2009 - 07/2008
2CCAAT-Enhancer-Binding Protein-betaIBA
10/2007 - 03/2004
2LipopolysaccharidesIBA
09/2006 - 08/2003
2EndotoxinsIBA
09/2006 - 08/2003
2CarcinogensIBA
03/2006 - 01/2004
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1Vasopressins (Vasopressin)IBA
10/2016
1EnzymesIBA
05/2015
1LuteolinIBA
05/2015
1Tryptophan (L-Tryptophan)FDA Link
05/2015
1Doxorubicin (Adriamycin)FDA LinkGeneric
05/2015
1Air Pollutants (Pollutants, Air)IBA
05/2015
1Phosphotransferases (Kinase)IBA
05/2015
1KynurenineIBA
05/2015
1FlavonoidsIBA
05/2015
1Estrogens (Estrogen)FDA Link
05/2015
1Paclitaxel (Taxol)FDA LinkGeneric
05/2015
1Lapatinib (GW572016)FDA Link
05/2015
1Prostaglandin-E SynthasesIBA
02/2014
1Phospholipases (Phospholipase)IBA
02/2014
1N 30IBA
12/2012
1Immunoglobulin E (IgE)IBA
12/2012
1Interleukin-22 (IL-22)IBA
12/2012
1Biomarkers (Surrogate Marker)IBA
06/2012
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2011
1DNA (Deoxyribonucleic Acid)IBA
08/2011
1InterleukinsIBA
08/2011
1Apolipoproteins E (ApoE)IBA
06/2011
1ApolipoproteinsIBA
06/2011
1EicosanoidsIBA
11/2010
1Aryl Hydrocarbon Receptor Nuclear TranslocatorIBA
11/2010
1N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA
11/2010
1MorpholinosIBA
11/2010
1parthenolideIBA
10/2010
1Mucin 5ACIBA
02/2010
1MucinsIBA
02/2010
1Estrogen Receptor alphaIBA
07/2009
1ProstaglandinsIBA
12/2008
1ElectrolytesIBA
09/2008
1Prostaglandins EIBA
09/2008
1Phospholipases A2 (Phospholipase A2)IBA
07/2008
1ArsenicIBA
03/2008
1arseniteIBA
03/2008
1NF-kappa B (NF-kB)IBA
03/2008
1Insulin (Novolin)FDA Link
10/2007
1PesticidesIBA
07/2007
1Hexachlorocyclohexane (gamma-Hexachlorocyclohexane)FDA LinkGeneric
07/2007
1Corn Oil (Oil, Corn)IBA
07/2007
1Indicators and Reagents (Reagents)IBA
11/2006
1Transcription Factors (Transcription Factor)IBA
11/2006
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
11/2006
1delta-hexachlorocyclohexaneIBA
03/2006
1Heptachlor EpoxideIBA
03/2006
1CalciumIBA
03/2006